Market Closed -
Japan Exchange
02:00:00 2024-05-21 am EDT
|
5-day change
|
1st Jan Change
|
309
JPY
|
-8.85%
|
|
-25.72%
|
-33.69%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,087,401
|
557,406
|
765,586
|
479,930
|
321,807
|
134,682
|
-
|
-
|
Enterprise Value (EV)
1 |
937,295
|
724,961
|
816,227
|
545,994
|
524,701
|
158,122
|
437,473
|
443,550
|
P/E ratio
|
22.4
x
|
13.7
x
|
13.6
x
|
8.51
x
|
-4.32
x
|
-0.5
x
|
-2.51
x
|
-6.86
x
|
Yield
|
1.02%
|
2%
|
1.45%
|
2.32%
|
2.59%
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.37
x
|
1.15
x
|
1.48
x
|
0.86
x
|
0.58
x
|
0.5
x
|
0.39
x
|
0.38
x
|
EV / Revenue
|
2.04
x
|
1.5
x
|
1.58
x
|
0.97
x
|
0.94
x
|
0.5
x
|
1.28
x
|
1.24
x
|
EV / EBITDA
|
13
x
|
7.21
x
|
8.69
x
|
5.54
x
|
9.11
x
|
-0.5
x
|
14.9
x
|
21.2
x
|
EV / FCF
|
23.8
x
|
-2.72
x
|
5.65
x
|
42.1
x
|
-13
x
|
-3.36
x
|
-16.5
x
|
-219
x
|
FCF Yield
|
4.21%
|
-36.8%
|
17.7%
|
2.37%
|
-7.72%
|
-29.8%
|
-6.05%
|
-0.46%
|
Price to Book
|
2.18
x
|
1.05
x
|
1.32
x
|
0.79
x
|
0.79
x
|
1.01
x
|
0.79
x
|
0.9
x
|
Nbr of stocks (in thousands)
|
397,297
|
397,295
|
397,294
|
397,293
|
397,292
|
397,291
|
-
|
-
|
Reference price
2 |
2,737
|
1,403
|
1,927
|
1,208
|
810.0
|
339.0
|
339.0
|
339.0
|
Announcement Date
|
5/10/19
|
5/13/20
|
5/12/21
|
5/13/22
|
5/15/23
|
5/14/24
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
459,267
|
482,732
|
515,952
|
560,035
|
555,544
|
314,558
|
343,060
|
359,056
|
EBITDA
1 |
71,860
|
100,604
|
93,897
|
98,582
|
57,627
|
-317,094
|
29,300
|
20,929
|
EBIT
1 |
57,884
|
83,239
|
71,224
|
60,234
|
-76,979
|
-354,859
|
-35,740
|
-15,766
|
Operating Margin
|
12.6%
|
17.24%
|
13.8%
|
10.76%
|
-13.86%
|
-112.81%
|
-10.42%
|
-4.39%
|
Earnings before Tax (EBT)
1 |
65,046
|
83,947
|
77,851
|
82,961
|
-47,920
|
-323,114
|
-64,548
|
-18,631
|
Net income
1 |
48,627
|
40,753
|
56,219
|
56,413
|
-74,512
|
-314,969
|
-53,739
|
-19,626
|
Net margin
|
10.59%
|
8.44%
|
10.9%
|
10.07%
|
-13.41%
|
-100.13%
|
-15.66%
|
-5.47%
|
EPS
2 |
122.4
|
102.6
|
141.5
|
142.0
|
-187.6
|
-792.8
|
-135.3
|
-49.40
|
Free Cash Flow
1 |
39,446
|
-266,556
|
144,476
|
12,961
|
-40,482
|
-127,120
|
-26,484
|
-2,027
|
FCF margin
|
8.59%
|
-55.22%
|
28%
|
2.31%
|
-7.29%
|
-40.19%
|
-7.72%
|
-0.56%
|
FCF Conversion (EBITDA)
|
54.89%
|
-
|
153.87%
|
13.15%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
81.12%
|
-
|
256.99%
|
22.98%
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
28.00
|
28.00
|
28.00
|
28.00
|
21.00
|
-
|
-
|
-
|
Announcement Date
|
5/10/19
|
5/13/20
|
5/12/21
|
5/13/22
|
5/15/23
|
5/14/24
|
-
|
-
|
Fiscal Period: March |
2020 S1
|
2020 S2
|
2021 S1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 S1
|
2025 Q3
|
2025 Q4
|
2026 S1
|
---|
Net sales
1 |
230,603
|
252,129
|
261,498
|
162,534
|
293,730
|
138,342
|
127,963
|
159,876
|
159,400
|
319,300
|
140,976
|
-
|
75,700
|
76,942
|
152,642
|
82,386
|
79,530
|
82,634
|
80,800
|
166,420
|
87,000
|
80,400
|
177,456
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-21,646
|
-
|
9,100
|
4,800
|
-
|
9,600
|
5,800
|
-
|
EBIT
1 |
66,835
|
16,404
|
47,539
|
39,266
|
47,572
|
10,656
|
2,006
|
14,614
|
-43,500
|
-28,900
|
11,138
|
-
|
-51,600
|
-34,898
|
-86,498
|
-31,247
|
-231,492
|
-18,664
|
-
|
-36,422
|
-
|
-
|
-9,217
|
Operating Margin
|
28.98%
|
6.51%
|
18.18%
|
24.16%
|
16.2%
|
7.7%
|
1.57%
|
9.14%
|
-27.29%
|
-9.05%
|
7.9%
|
-
|
-68.16%
|
-45.36%
|
-56.67%
|
-37.93%
|
-291.08%
|
-22.59%
|
-
|
-21.89%
|
-
|
-
|
-5.19%
|
Earnings before Tax (EBT)
1 |
64,147
|
19,800
|
43,654
|
41,309
|
49,266
|
16,317
|
17,378
|
46,610
|
-25,610
|
21,000
|
-18,842
|
-
|
-31,100
|
-25,027
|
-56,127
|
-49,064
|
-217,923
|
-10,927
|
-7,400
|
-36,602
|
-2,600
|
-6,200
|
-9,397
|
Net income
1 |
30,330
|
10,423
|
37,297
|
31,650
|
36,450
|
9,909
|
10,054
|
31,108
|
-38,400
|
-7,300
|
-11,219
|
-
|
-38,900
|
-28,841
|
-67,741
|
-49,967
|
-197,261
|
-7,782
|
-3,500
|
-27,452
|
-1,200
|
-11,200
|
-7,048
|
Net margin
|
13.15%
|
4.13%
|
14.26%
|
19.47%
|
12.41%
|
7.16%
|
7.86%
|
19.46%
|
-24.09%
|
-2.29%
|
-7.96%
|
-
|
-51.39%
|
-37.48%
|
-44.38%
|
-60.65%
|
-248.03%
|
-9.42%
|
-4.33%
|
-16.5%
|
-1.38%
|
-13.93%
|
-3.97%
|
EPS
2 |
76.34
|
-
|
93.88
|
79.66
|
91.75
|
24.94
|
25.30
|
78.30
|
-96.63
|
-18.33
|
-28.24
|
-141.0
|
-97.82
|
-72.69
|
-170.5
|
-125.8
|
-496.5
|
-35.40
|
-
|
-69.10
|
-
|
-
|
-17.70
|
Dividend per Share
2 |
14.00
|
-
|
14.00
|
-
|
14.00
|
-
|
-
|
-
|
-
|
14.00
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/28/19
|
5/13/20
|
10/28/20
|
10/27/21
|
10/27/21
|
1/31/22
|
5/13/22
|
7/29/22
|
10/31/22
|
10/31/22
|
1/31/23
|
5/15/23
|
7/31/23
|
10/31/23
|
10/31/23
|
1/31/24
|
5/14/24
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
167,555
|
50,641
|
66,064
|
202,894
|
292,323
|
302,792
|
308,869
|
Net Cash position
1 |
150,106
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
1.665
x
|
0.5393
x
|
0.6701
x
|
3.521
x
|
-1.771
x
|
10.33
x
|
14.76
x
|
Free Cash Flow
1 |
39,446
|
-266,556
|
144,476
|
12,961
|
-40,482
|
-127,121
|
-26,484
|
-2,027
|
ROE (net income / shareholders' equity)
|
10.2%
|
7.9%
|
10.1%
|
9.5%
|
-14.7%
|
-112%
|
-24.4%
|
-7.8%
|
ROA (Net income/ Total Assets)
|
7.91%
|
8.04%
|
4.38%
|
6.34%
|
-3.92%
|
-31.6%
|
-7.4%
|
-2.79%
|
Assets
1 |
614,659
|
506,723
|
1,283,539
|
889,478
|
1,899,145
|
995,384
|
655,397
|
750,201
|
Book Value Per Share
2 |
1,254
|
1,333
|
1,461
|
1,530
|
1,024
|
393.0
|
432.0
|
378.0
|
Cash Flow per Share
2 |
158.0
|
146.0
|
199.0
|
239.0
|
-83.70
|
-698.0
|
-209.0
|
71.90
|
Capex
1 |
9,265
|
7,722
|
6,048
|
7,347
|
14,600
|
14,080
|
12,280
|
12,280
|
Capex / Sales
|
2.02%
|
1.6%
|
1.17%
|
1.31%
|
2.63%
|
4.45%
|
3.58%
|
3.47%
|
Announcement Date
|
5/10/19
|
5/13/20
|
5/12/21
|
5/13/22
|
5/15/23
|
5/14/24
|
-
|
-
|
Mean consensus UNDERPERFORM Average target price
333.8
JPY Spread / Average Target -1.55% Consensus |
1st Jan change
|
Capi.
|
---|
| -33.69% | 863M | | +34.35% | 705B | | +30.53% | 583B | | -3.49% | 364B | | +20.15% | 332B | | +6.19% | 291B | | +15.83% | 238B | | -3.44% | 210B | | +10.46% | 209B | | +9.21% | 169B |
Other Pharmaceuticals
|